1 |
Corry DB, Tuck ML. 2002. Protection from vascular risk in diabetic by pretension. Curr Hyperten Rep 2: 154-159.
|
2 |
Baron AD. 1998. Postprandial hyperglycemia and -glucosidase inhibitors. Diabetes Res Clin Pract 40: S51-55.
DOI
ScienceOn
|
3 |
UK Prospective Diabetes Study Group. 1998. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837- 853.
DOI
ScienceOn
|
4 |
Saito N, Sakai H, Sekihara H, Yajima Y. 1998. Effect of an -glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycaemic control in type 2 diabetes patients. J Int Med Res 26: 219-232.
DOI
|
5 |
Holman RR, Cull CA, Turner RC. 1999. A randomized double- blind trial of acarbose in type 2 diabetes shows improved glycaemic control over 3 years (U.K. Prospective Diabetes study 44). Diabetes Care 22: 960-964.
DOI
ScienceOn
|
6 |
Toeller M. 1994. -Glucosidase inhibitiors in diabetes: efficacy in NIDDM subjects. Eur J Clin Invest 24: 31-35.
|
7 |
Clissold SP, Edwards C. 1988. A preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic potential. Drugs 35: 214-243.
|
8 |
Casirola DM, Ferraris RP. 2006. Alpha-glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice. Metabolism 55: 832-841.
DOI
ScienceOn
|
9 |
Sels JP, Huijberts MS, Wolffenbuttel BH. 1999. Miglitol, a new alpha-glucosidase inhibitor. Expert Opin Pharmacother 1: 149-156.
DOI
ScienceOn
|
10 |
Stand E, Baumgartl HJ, Fuchtenbusch M, Stemplinger J. 1999. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes Metab 1: 125-220.
|
11 |
Hanefeld M. 1998. The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complicat 12: 228-237.
DOI
ScienceOn
|
12 |
Hsiao SH, Liao LH, Cheng PN, Wu TJ. 2006. Hepatotoxicity associated with acarbose therapy. Ann Pharmacother 40: 151-154.
DOI
|
13 |
Chandini SK, Ganesan P, Bhaskar N. 2008. In vitro antioxidant activities of three selected brown seaweeds of India. Food Chem 107: 707-713.
DOI
ScienceOn
|
14 |
Kang JY, Khan MNA, Park NH, Cho JY, Lee MC, Fujii H, Hong YK. 2008. Antipyretic, analgesic, and anti-inflammatory activities of the seaweed Sargassum fulvellum and Sargassum thunbergii in mice. J Ethnopharmacol 116: 187-190.
DOI
ScienceOn
|
15 |
Fukuyama Y, Kodama M, Miura I, Kinzyo Z, Kido M, Mori H, Nakayama Y, Takahashi M. 1989. Structure of an anti-plasmin inhibitor, eckol, isolated from the brown alga Ecklonia kurome Okamura and inhibitory activities of its derivatives on plasma plasmin inhibitors. Chem Pharm Bull 37: 349-353.
DOI
ScienceOn
|
16 |
Lee SH, Min KH, Han JS, Lee DH, Park DB, Jung WK, Park PJ, Jeon BT, Kim SK, Jeon YJ. 2012. Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus. Food Chem Toxicol 50: 575-582.
DOI
ScienceOn
|
17 |
Chung HY, Ma WC, Ang PO Jr, Kim JS, Chen F. 2003. Seasonal variations of bromophenols in brown algae (Padina arborescens, Sargassum siliquastrum, and Lobophora variegate) collected in Hong Kong. J Agric Food Chem 51: 2619-2624.
DOI
ScienceOn
|
18 |
Watanabe J, Kawabata J, Kurihara H, Niki R. 1997. Isolation and identification of alpha-glucosidase inhibitors from tochucha (Eucommia ulmoides). Biosci Biotechnol Biochem 61: 177-178.
DOI
ScienceOn
|
19 |
Fautz R, Husen B, Hechenberger C. 1991. Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutat Res 253: 173-179.
DOI
ScienceOn
|
20 |
Kim JS. 2004. Effect of Rhemanniae radix on the hyperglycemic mice induced with streptozotocin. J Korean Soc Food Sci Nutr 33: 1133-1138.
과학기술학회마을
DOI
ScienceOn
|
21 |
Prashanth D, Samiulla DS, Padmaja R. 2001. Effect of certain plant extracts on -amylase activity. Fitoterapia 72: 179-181.
DOI
ScienceOn
|
22 |
Cheng AYY, Fantus IG. 2005. Oral antihyperglycemic therapy for type 2 diabetes mellitus. Can Med Assoc J 172: 213-226.
DOI
ScienceOn
|
23 |
Hanefeld M, Schaper F. 2007. The role of alpha-glucosidase inhibitors (acarbose). In Pharmacotherapy of Diabetes: New Developments Improving Life and Prognosis for Diabetic Patients. Springer Science, New York, NY, USA. p 143-152.
|
24 |
Abrahamson MJ. 2004. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Arch Intern Med 164: 486-491.
DOI
ScienceOn
|
25 |
Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J. 2006. International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 16: 453-456.
DOI
ScienceOn
|
26 |
Inoue I, Takahashi K, Noji S, Awata T, Negishi K, Katayama S. 1997. Acarbose controls postprandial hyper-proinsulinemia in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 36: 143-151.
DOI
ScienceOn
|
27 |
Dennis JW, Laferte S, Waghorne C, Breitman ML, Kergel RS. 1987. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236: 582-585.
DOI
|
28 |
Lee SH, Park MH, Heo SJ, Kang SM, Ko SC, Han JS. 2010. Dieckol isolated from Ecklonia cava inhibits -glucosidase and -amylase in vitro and alleviates postprandial hyperglycemia in streptozocin-induced diabetic mice. Food Chem Toxicol 48: 2633-2637.
DOI
ScienceOn
|
29 |
Nam JS, Lee WJ, Yoon IS, Kang MW, Jang HS, Youn JH, Kim BR, Kong HJ, Kim KH, Kim YH, Lee DS, Choi HJ. 2007. Effect of a brown algae extract on postprandial glucose control in neonatal diabetic and obese rats. J FASEB 21: 845.2.
|